Literature DB >> 15633839

The legal and clinical implications of crushing tablet medication.

Anthony James1.   

Abstract

It has recently been estimated that 75 per cent of all older patients will fail to comply with their medication regimes at some point during their hospital stay (Wright, 2002). Crushing tablets or opening capsules in order to assist a patient with swallowing difficulties appears to be a widespread activity. There may be times when tablets will need to be crushed in order to deliver essential drug therapy; this should only be done as a last resort. Crushing tablets is a practice that has the potential to endanger patient safety and contravene legal and professional requirements.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15633839

Source DB:  PubMed          Journal:  Nurs Times        ISSN: 0954-7762


  5 in total

Review 1.  Older adults with difficulty swallowing oral medicines: a systematic review of the literature.

Authors:  Aoife Mc Gillicuddy; Abina M Crean; Laura J Sahm
Journal:  Eur J Clin Pharmacol       Date:  2015-11-16       Impact factor: 2.953

2.  A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers.

Authors:  Ramesh Boinpally; Laishun Chen; Stephen R Zukin; Natalie McClure; Robert K Hofbauer; Antonia Periclou
Journal:  Clin Drug Investig       Date:  2015-07       Impact factor: 2.859

Review 3.  Oral drug therapy in elderly with dysphagia: between a rock and a hard place!

Authors:  Serena Logrippo; Giovanna Ricci; Matteo Sestili; Marco Cespi; Letizia Ferrara; Giovanni F Palmieri; Roberta Ganzetti; Giulia Bonacucina; Paolo Blasi
Journal:  Clin Interv Aging       Date:  2017-01-31       Impact factor: 4.458

4.  Oral medicine modification for older adults: a qualitative study of nurses.

Authors:  Aoife Mc Gillicuddy; Abina M Crean; Maria Kelly; Laura Sahm
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

5.  Rivaroxaban concentrations in acute stroke patients with different dosage forms.

Authors:  Shinichi Wada; Manabu Inoue; Takayuki Matsuki; Takuya Okata; Masaya Kumamoto; Naoki Tagawa; Akira Okamoto; Toshiyuki Miyata; Masafumi Ihara; Masatoshi Koga; Kazunori Toyoda
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.